This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
|Articles|February 2, 2017
- Pharmaceutical Technology-02-02-2017
- Volume 41
- Issue 2
Explosion Proof Mixer and Discharge System
The 10-gallon Double Planetary Mixer and Discharge System from Ross, Charles & Son has heavy-duty helical mixing blades, designed for high-viscosity pastes, gels, and putty-like materials.
The 10-gallon Double Planetary Mixer and Discharge System from Ross, Charles & Son has heavy-duty helical mixing blades, designed for high-viscosity pastes, gels, and putty-like materials. The blades are raised and lowered via an air/oil hydraulic lift with explosion-proof electrically operated solenoid valves. The motors on the mixer and discharge system, limit switches, junction box, local operator station, platform scale, and weight indicator are all explosion-proof. All hardware in the mixing zone are lock-wired. Product wetted welds are dye-penetration tested.
The vacuum-rated mix can is internally machined, providing uniform stirrer-to-vessel clearances of 1/4 to 1/2 in. Other features include a 50-psig stainless steel jacket for heating/cooling, two-inch flush cove-cut discharge valve, resistance temperature detectors thermocouple on the sidewall, and a grounding drag strap. Caster wheels on the vessel and V-tracks on the platform allow for movement between the mixer, weighing station, and discharge press.
Articles in this issue
over 9 years ago
A Risk-Based Approach to Stainless Steel Equipment Maintenanceover 9 years ago
Pumping Fluids in Biopharmaceutical Processingover 9 years ago
Moving Forward with Adaptive Licensingover 9 years ago
Collaboration Key to Meeting Excipient GMP Requirementsover 9 years ago
Regulatory Reform Is Not That Simpleover 9 years ago
Mass Spec Sheds New Light on Biologics Drug Developmentover 9 years ago
Evaluating E&L Studies for Single-Use Systemsover 9 years ago
Ensuring Sterility in Small-Scale Productionover 9 years ago
Viewpoint: Challenges and Opportunities for CDMOsRelated to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Trending on Pharmaceutical Technology
1
PharmTech Weekly Roundup—September 18, 2026
2
Introducing the "PharmTech AI Pulse Check" Expert Video Series
3
Can AI Agents Satisfy CGMP Documentation Requirements?
4
Two Audit Case Studies Reveal the Cost of Incomplete Corrective Actions
5